Download PDF
Arzneimittelforschung 2010; 60(7): 415-420
DOI: 10.1055/s-0031-1296305
Review
Editio Cantor Verlag Aulendorf (Germany)

Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: a systematic review of previous literature

Francesco Libero Giorgino
1   Faculty of Medicine and Surgery, University of Padova, Padova, Italy
2   Associazione Ginecologi Extra Ospedalieri, Padova, Italy
,
Colin Gerard Egan
3   Primula Multimedia S.R.L., Pisa, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

    Permissions and Reprints

Abstract

The aim of this systematic review was to evaluate the efficacy of isoxsuprine (1-(4-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-1-propanol, CAS 395-28-8), a tocolytic agent used in both preterm labour and risk of abortion.

Two analyses were conducted on data reporting the use of isoxsuprine in the prevention of preterm delivery. The first analysis examined two double-blind studies to determine the effect of isoxsuprine compared to placebo. The second analysis reviewed data from 25 publications containing individual and general patient data. Main outcome measures included delay of pregnancy and patient outcome.

Analysis of double-blind studies demonstrated a positive outcome with isoxsuprine in 92% of cases compared to placebo control (44.4%, p < 0.001). This beneficial effect was maintained when either risk of abortion (92.5% in isoxsuprine treated compared to 46.4% in placebo, p < 0.001) or risk of premature delivery (89.5% in isoxsuprine treated compared to 29.4% in placebo, p < 0.001) was examined. Secondary analysis of individual patient data also revealed a beneficial effect of isoxsuprine in prolonging pregnancy in 54.5% of women at risk of abortion and in 82.3% of women at risk of premature delivery. Combination of individual and general data revealed a beneficial effect of isoxsuprine in 77.3% of cases at risk of abortion and 89% for risk of premature delivery.

These findings provide preliminary evidence in favour of the effectiveness of isoxsuprine in prolonging pregnancy in women at risk of abortion or premature delivery.

Key words

Abortion - CAS 395-28-8 - Isoxsuprine hydrochloride - Pregnancy - Preterm labour - Tocolytic
 

  • References

  • 1 Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. Br Med J. 1976; 2 (6042) 965-8
    CrossrefPubMedGoogle Scholar
  • 2 Tough SC, Greene CA, Svenson LW, Belik J. Effects of in vitro fertilization on low birth weight, preterm delivery, and multiple birth. J Pediatr. 2000; 136 (5) 618-22
    CrossrefPubMedGoogle Scholar
  • 3 Tough SC, Newbum-Cook C, Johnston DW, Svenson LW, Rose S, Belik J. Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. Pediatrics. 2002; 109 (3) 399-403
    CrossrefPubMedGoogle Scholar
  • 4 ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin Management of preterm labor. Number 43, May 2003 Int J Gynaecol Obstet. 2003; 82: 127-35
    CrossrefPubMedGoogle Scholar
  • 5 Takagi K, Satoh T. Is long-term tocolysis effective for threatened premature labour?. J Int Med Res. 2009; 37: 227-39
    PubMedGoogle Scholar
  • 6 Keirse MJ. New perspectives for the effective preterm labor. Am. J Obstet Gynecol. 1995; 173: 618-28
    CrossrefPubMedGoogle Scholar
  • 7 Keirse MJ. The history of tocolysis. BJOG. 2003; 110: 94-7
    CrossrefPubMedGoogle Scholar
  • 8 Bishop EH, Woutersz TB. Arrest of premature labor. JAMA. 1961; 178: 812-4
    CrossrefPubMedGoogle Scholar
  • 9 Hendricks CH, Cibils LA, Pose SV, Eskes TK. The pharmacologic control of excessive uterine activity with isoxsuprine. Am J Obstet Gynecol. 1961; 82: 1064-78
    CrossrefPubMedGoogle Scholar
  • 10 Okatomi T, Rimura Y. Clinical trial of Duvadilan (isoxsuprine HC1) and its uterine antispasmodic effect. Sanka to Fujinka. 1962; 29: 1-24
    PubMedGoogle Scholar
  • 11 Karim M. Isoxsuprine and the human parturient uterus: a clinical and tocographic study. Obstet Gynaecol Br Commonw. 1963; 70: 992-5
    PubMedGoogle Scholar
  • 12 Klurfan HI, Casavilla F, Demartire JB, De EMOtero. Effect of isoxsuprine on the contractility of the uterus: clinical analysis. Proc Soc Obst Ginecol (Buenos Aires). 1963; 285: 90
    PubMedGoogle Scholar
  • 13 Allen HH, Short H, Fraleigh DM. The use of isoxsuprine in the management of premature labor. Appl Ther. 1965; 7: 544-7
    PubMedGoogle Scholar
  • 14 Renaud R, Vetter B, Remlinger L, Chesnet Y. [Effect of isoxsuprine in threat of premature delivery]. Bull Fed Soc Gynecol Obstet Lang Fr. 1965; 17: 271-2 French
    PubMedGoogle Scholar
  • 15 Lucisano F, Casini E, Cotroneo G. [Use of isoxsuprine in childbirth]. Clin Ostet Ginecol. 1967; 8: 390-8 Italian
    PubMedGoogle Scholar
  • 16 Cazzola D. [Effects of isoxsuprine hydrochloride in threatened abortion]. Quad Clin Ostet Ginecol. 1967; 22: 382-96 Italian
    PubMedGoogle Scholar
  • 17 Benfatto G, Costernino A. [Use of isoxsuprine in obstetrics]. Clin Ginecol. 1968; 10: 299-319 Italian
    PubMedGoogle Scholar
  • 18 Scillieri P, Grossi F. [Treatment of threatened abortion and premature labor with isoxsuprine hydrochloride]. Arch Ostet Ginecol. 1971; 76: 129-37 Italian
    PubMedGoogle Scholar
  • 19 Signorelli I, Rella R. [Use of isoxsuprine in the obstetrical pathology]. Arch Ostet Ginecol. 1972; 77: 115-28 Italian
    PubMedGoogle Scholar
  • 20 Ballestrin L. [Isoxsuprine chlorhydrate in the treatment of threatened abortion]. Arch Ostet Ginecol. 1973; 78: 53-66 Italian
    PubMedGoogle Scholar
  • 21 Tomassini A, Razzini M, Zocchi G, Caprioli E. [Interpretative analysis of 50 cases of tocolysis treated with isoxsuprine]. Min Gin. 1974; 26: 1-13 Italian
    PubMedGoogle Scholar
  • 22 Brazy JE, Little V, Grimm J, Pupkin M. Risk:benefit considerations for the use of isoxsuprine in the treatment of premature labor. Obstet Gynecol. 1981; 58 (3) 297-303
    PubMedGoogle Scholar
  • 23 Moggian G, Zulli P, Aquilina M, Tamburini E. [Effects of isoxsuprine in threatened premature labor and in labor (clinical contribution of 158 cases)] . Riv Ital Ginecol. 1976; 57: 363-416 Italian
    PubMedGoogle Scholar
  • 24 Sola O, Colonna-Romano L. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion]. Arch Ostet Ginecol. 1974; 79: 326-35 Italian
    PubMedGoogle Scholar
  • 25 Verrocchi G, Santarelli P. [Treatment for risk of premature delivery with Vasosuprina]. Riv Ostet Ginec Pratica Med Perin. 1977; 57: 69-73 Italian
    PubMedGoogle Scholar
  • 26 Polito PM, De VPalama, De ACurtis. [The use of isoxsuprine in threatened premature labor]. Minerva Ginecol. 1975; 4: 329-32 Italian
    PubMedGoogle Scholar
  • 27 Oliva GC, Caglione R, Romanini C, Bompiani A. [New aspects in tocolytic maintenance therapy: use of isoxsuprine as a contracting agent]. Agg Ost Gin. 1976; 9: 405-12 Italian
    PubMedGoogle Scholar
  • 28 Csapo AI, Herczeg J. Arrest of premature labor by isoxsuprine. Am] Obstet Gynecol. 1977; 129: 482-91
    PubMedGoogle Scholar
  • 29 Julitta A, Bonito L, Fornaroli G. [On the use of isoxysuprine in threatened abortion]. Minerva Ginecol. 1969; 21: 867-8 Italian
    PubMedGoogle Scholar
  • 30 Schenken RS, Hayashi RH, Valenzuela GV, Castello MS. Treatment of premature labor with beta sympathomimetics: results with isoxsuprine. Am J Obstet Gynecol. 1980; 137: 773-80
    CrossrefPubMedGoogle Scholar
  • 31 Chieri S, Maffeo G. [The use of isoxsuprine hydrochloride in the therapy of threatened abortion]. Minerva Ginecol. 1962; 14: 689-93 Italian
    PubMedGoogle Scholar
  • 32 Stefanini U, Ferruti M. [Treatment with isoxsuprine in risk for risk of abortion]. Il Bassini. 1967; 12: 1-10
    PubMedGoogle Scholar
  • 33 Marzo A, Zava M, Coa K, Dal LBo, Ismaili S, Tavazzi S et al Pharmacokinetics of isoxsuprine hydrochloride administered orally and intramuscularly to female healthy volunteers. Arzneimittelforschung. 2009; 59 (9) 455-60
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Leep JH. Current concepts in obstetrics and gynecology. Isoxsuprine in the prevention of abortion: preliminary report. West J Surg Obstet Gynecol. 1963; 71: vi-viii passim
    PubMedGoogle Scholar
  • 35 Mathews DD, Friend JB, Michael CA. A double-blind trial of oral isoxsuprine in the prevention of premature labour. Obstet Gynaecol Br Commonw. 1967; 74 (1) 68-70
    PubMedGoogle Scholar
  • 36 Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Hari-gopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004; (4) CD004352
    PubMedGoogle Scholar
  • 37 Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev. 2002; (4) CD003933
    PubMedGoogle Scholar
  • 38 Tan TC, Devendra K, Tan LK, Tan HK. Tocolytic treatment for the management of preterm labour: a systematic review. Singapore Med J. 2006; 47 (5) 361-6
    PubMedGoogle Scholar
  • 39 Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev. 2006; (1) CD003927
    PubMedGoogle Scholar
  • 40 King JF, Grant A, Keirse MJ. Beta-mimetics in preterm labour: an overview of randomized controlled trials. Br J Obst Gynecol. 1988; 93: 211-22
    PubMedGoogle Scholar
  • 41 Laros Jr RK, Kitterman JA, Heilbron DC, Cowan RM, Tooley WH. Outcome of very-low-birth-weight infants exposed to beta-sympathomimetics in utero. Am J Obstet Gynecol. 1991; 164: 1657-64
    PubMedGoogle Scholar
  • 42 Brazy JE, Little V, Grimm J. Isoxsuprine in the perinatal period. Relationships between neonatal symptoms, drug exposure and drug concentration at time of birth. J Pediatr. 1981; 98: 146-51
    CrossrefPubMedGoogle Scholar
  • 43 Blea CW, Barnard JM, Magness RR, Phemetton TM, Hendricks SK. Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe. Am J Obstet Gynecol. 1997; 176: 922-30
    CrossrefPubMedGoogle Scholar
  • 44 Keirse MJ. Betamimetic drugs in the prophylaxis of preterm labour: extent and rationale of their use. Br J Obstet Gynaecol. 1984; 91: 431-37
    PubMedGoogle Scholar
  • 45 Keirse MJ. A survey of tocolytic drug treatment in preterm labour. Br J Obstet Gynaecol. 1984; 91: 424-30
    PubMedGoogle Scholar